Skip to main content

Table 2 Misclassifications of pathology in the initially misdiagnosed group a

From: Challenge in pathologic diagnosis of Alport syndrome: evidence from correction of previous misdiagnosis

Corrected diagnosis

Previous misdiagnosis

N

% in subgroup

% in whole group

fXLAS

 

23

 

44.2

 

FSGS

8

34.8

15.4

 

MsPGN

5

21.7

9.6

 

IgAN (mesangial proliferation)

4

17.4

7.7

 

TBMN

3

13.0

5.8

 

MCD

2

8.7

3.8

 

IgMN

1

4.3

1.9

mXLAS

 

17

 

32.7

 

MsPGN

7

41.2

13.5

 

IgAN (MsP)

2

11.8

3.8

 

IgAN (with FGS)

2

11.8

3.8

 

IMN

2

11.8

3.8

 

FSGS

2

11.8

3.8

 

HTN

1

5.9

1.9

 

D_TIN

1

5.9

1.9

ARAS

 

12

 

23.1

 

MCD

2

16.7

3.8

 

MsPGN

2

16.7

3.8

 

MN

2

16.7

3.8

 

IgAN (mesangial proliferation)

1

8.3

1.9

 

TBMN

1

8.3

1.9

 

IgM nephropathy

1

8.3

1.9

 

MPGN

1

8.3

1.9

 

Pregnancy related nephropathy

1

8.3

1.9

 

Obesity related nephropathy

1

8.3

1.9

  1. aFSGS, focal segmental glomerulosclerosis; MsPGN, mesangial proliferative glomerulonephritis; IgAN, IgA nephropathy; TBMN, thin basement membrane nephropathy; MCD, minor change disease; IMN, idiopathic membranous nephropathy; HTN, hypertensive nephropathy; D-TIN, drug-induced tubulointerstitial nephritis; MPGN, membranous proliferative glomerulonephritis.
Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172